1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Reverter, D.
Fernandez-Catalan, C.
Bode, W.
Holak, T.A.
Aviles, F.X.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
7
322
328
10.1038/74092
10742178
Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2.
2000
10.2210/pdb1dtv/pdb
pdb_00001dtv
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
7397.256
CARBOXYPEPTIDASE INHIBITOR
1
nat
polymer
LCI
no
no
GSHTPDESFLCYQPDQVCCFICRGAAPLPSEGECNPHPTAPWCREGAVEWVPYSTGQCRTTCIPYVE
GSHTPDESFLCYQPDQVCCFICRGAAPLPSEGECNPHPTAPWCREGAVEWVPYSTGQCRTTCIPYVE
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
medicinal leech
Hirudo
sample
6421
Hirudo medicinalis
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2000-07-19
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
RCSB
Y
RCSB
2000-01-13
REL
structures with the lowest energy
15
1
2D NOESY
20mM Tris
6.5
ambient
298
K
simulated annealing
1
closest to the average
1 mM in 20 mM phosphate buffer, pH 6.5
90% H2O/10% D2O
Brunger
refinement
X-PLOR
3.1
600
Bruker
DRX
GLY
1
n
1
GLY
1
A
SER
2
n
2
SER
2
A
HIS
3
n
3
HIS
3
A
THR
4
n
4
THR
4
A
PRO
5
n
5
PRO
5
A
ASP
6
n
6
ASP
6
A
GLU
7
n
7
GLU
7
A
SER
8
n
8
SER
8
A
PHE
9
n
9
PHE
9
A
LEU
10
n
10
LEU
10
A
CYS
11
n
11
CYS
11
A
TYR
12
n
12
TYR
12
A
GLN
13
n
13
GLN
13
A
PRO
14
n
14
PRO
14
A
ASP
15
n
15
ASP
15
A
GLN
16
n
16
GLN
16
A
VAL
17
n
17
VAL
17
A
CYS
18
n
18
CYS
18
A
CYS
19
n
19
CYS
19
A
PHE
20
n
20
PHE
20
A
ILE
21
n
21
ILE
21
A
CYS
22
n
22
CYS
22
A
ARG
23
n
23
ARG
23
A
GLY
24
n
24
GLY
24
A
ALA
25
n
25
ALA
25
A
ALA
26
n
26
ALA
26
A
PRO
27
n
27
PRO
27
A
LEU
28
n
28
LEU
28
A
PRO
29
n
29
PRO
29
A
SER
30
n
30
SER
30
A
GLU
31
n
31
GLU
31
A
GLY
32
n
32
GLY
32
A
GLU
33
n
33
GLU
33
A
CYS
34
n
34
CYS
34
A
ASN
35
n
35
ASN
35
A
PRO
36
n
36
PRO
36
A
HIS
37
n
37
HIS
37
A
PRO
38
n
38
PRO
38
A
THR
39
n
39
THR
39
A
ALA
40
n
40
ALA
40
A
PRO
41
n
41
PRO
41
A
TRP
42
n
42
TRP
42
A
CYS
43
n
43
CYS
43
A
ARG
44
n
44
ARG
44
A
GLU
45
n
45
GLU
45
A
GLY
46
n
46
GLY
46
A
ALA
47
n
47
ALA
47
A
VAL
48
n
48
VAL
48
A
GLU
49
n
49
GLU
49
A
TRP
50
n
50
TRP
50
A
VAL
51
n
51
VAL
51
A
PRO
52
n
52
PRO
52
A
TYR
53
n
53
TYR
53
A
SER
54
n
54
SER
54
A
THR
55
n
55
THR
55
A
GLY
56
n
56
GLY
56
A
GLN
57
n
57
GLN
57
A
CYS
58
n
58
CYS
58
A
ARG
59
n
59
ARG
59
A
THR
60
n
60
THR
60
A
THR
61
n
61
THR
61
A
CYS
62
n
62
CYS
62
A
ILE
63
n
63
ILE
63
A
PRO
64
n
64
PRO
64
A
TYR
65
n
65
TYR
65
A
VAL
66
n
66
VAL
66
A
GLU
67
n
67
GLU
67
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
ASN
35
A
O
ASN
35
A
N
LEU
10
A
N
LEU
10
A
N
GLN
13
A
N
GLN
13
A
O
GLN
16
A
O
GLN
16
A
O
ILE
21
A
O
ILE
21
A
N
ARG
59
A
N
ARG
59
A
O
GLY
56
A
O
GLY
56
A
N
TYR
53
A
N
TYR
53
1
A
A
O
OH
GLN
TYR
13
65
2.19
1
A
ARG
23
0.177
SIDE CHAIN
1
A
ARG
44
0.162
SIDE CHAIN
1
A
ARG
59
0.308
SIDE CHAIN
1
-3.83
0.60
121.00
117.17
A
A
A
CB
CG
CD2
TYR
TYR
TYR
65
65
65
N
1
A
SER
2
-112.05
-160.47
1
A
GLU
7
-118.17
-169.67
1
A
PRO
14
-57.26
-9.05
1
A
ASP
15
-143.94
15.63
1
A
ALA
25
-145.70
-148.87
1
A
PRO
38
-69.12
-129.47
1
A
THR
39
-162.35
107.44
1
A
ALA
40
-67.82
-172.27
1
A
SER
54
-20.81
-90.60
1
A
TYR
65
-109.95
-110.36
1
A
VAL
66
-76.24
26.44
NMR STRUCTURE OF THE LEECH CARBOXYPEPTIDASE INHIBITOR (LCI)
1
N
N
A
ALA
40
A
ALA
40
HELX_P
A
ALA
47
A
ALA
47
1
1
8
disulf
2.019
A
CYS
11
A
SG
CYS
11
1_555
A
CYS
34
A
SG
CYS
34
1_555
disulf
2.028
A
CYS
18
A
SG
CYS
18
1_555
A
CYS
62
A
SG
CYS
62
1_555
disulf
2.010
A
CYS
19
A
SG
CYS
19
1_555
A
CYS
43
A
SG
CYS
43
1_555
disulf
2.014
A
CYS
22
A
SG
CYS
22
1_555
A
CYS
58
A
SG
CYS
58
1_555
HYDROLASE INHIBITOR
Leech Carboxypeptidase Inhibitor, LCI, HYDROLASE INHIBITOR
MCPI_HIRME
UNP
1
15
P81511
SSHTPDESFLCYQPDQVCCFICRGAAPLPSEGECNPHPTAPWCREGAVEWVPYSTGQCRTTCIPYVE
15
81
1DTV
1
67
P81511
A
1
1
67
1
SER
conflict
GLY
1
1DTV
A
P81511
UNP
15
1
5
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
GLU
33
A
GLU
33
A
PRO
36
A
PRO
36
A
GLU
7
A
GLU
7
A
GLN
13
A
GLN
13
A
GLN
16
A
GLN
16
A
CYS
22
A
CYS
22
A
GLY
56
A
GLY
56
A
ILE
63
A
ILE
63
A
PRO
52
A
PRO
52
A
TYR
53
A
TYR
53
1
P 1